
Anna Bernaziuk
Insight-Driven advisory for a regulated industry
The pharmaceutical and medical industries in Poland have undergone significant transformation over the past two decades. The shift from state-owned to privately held enterprises, evolving healthcare regulations, market consolidation, and the increasing role of international investors have reshaped the sector. At the same time, the expansion of pharmacy and distribution networks, as well as the acceleration of digital innovation, have created both new opportunities and challenges.
In such a dynamic and highly regulated environment, success depends on partnering with an advisor who not only understands the complexity of the sector but also offers proven experience and industry insight. At BDO, we have been supporting pharmaceutical companies, healthcare providers, distributors, and investors for years—offering tailored solutions that address sector-specific challenges and support long-term growth.
Our expertise, your competitive advantage
Our team of professionals—including auditors, tax advisors, financial consultants, and business strategists—works closely with entities in the pharmaceutical and medical space. We know the regulatory landscape, market dynamics, and key performance drivers that define the industry today.
BDO’s core services for the pharmaceutical and medical sector:
Whether you're a pharmaceutical manufacturer, medical service provider, distributor, or healthcare investor, BDO is your partner in navigating regulatory complexity, optimizing performance, and securing sustainable success.
Let’s talk about how we can support your growth.